JP2011506433A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506433A5 JP2011506433A5 JP2010537898A JP2010537898A JP2011506433A5 JP 2011506433 A5 JP2011506433 A5 JP 2011506433A5 JP 2010537898 A JP2010537898 A JP 2010537898A JP 2010537898 A JP2010537898 A JP 2010537898A JP 2011506433 A5 JP2011506433 A5 JP 2011506433A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- protein
- seq
- composition according
- antigenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims 19
- 102000004169 proteins and genes Human genes 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 230000000890 antigenic effect Effects 0.000 claims 17
- 239000000427 antigen Substances 0.000 claims 10
- 102000036639 antigens Human genes 0.000 claims 10
- 108091007433 antigens Proteins 0.000 claims 10
- 229960005486 vaccine Drugs 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 241000194017 Streptococcus Species 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 239000013598 vector Substances 0.000 claims 4
- 241000283086 Equidae Species 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 206010041067 Small cell lung cancer Diseases 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 241000283073 Equus caballus Species 0.000 claims 1
- 206010061372 Streptococcal infection Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 230000005875 antibody response Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1349507P | 2007-12-13 | 2007-12-13 | |
| US8228108P | 2008-07-21 | 2008-07-21 | |
| PCT/SE2008/051445 WO2009075646A1 (en) | 2007-12-13 | 2008-12-12 | Improved immunizing composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011506433A JP2011506433A (ja) | 2011-03-03 |
| JP2011506433A5 true JP2011506433A5 (enExample) | 2012-01-19 |
Family
ID=40755754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010537898A Pending JP2011506433A (ja) | 2007-12-13 | 2008-12-12 | 改変された免疫組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20110020403A1 (enExample) |
| EP (1) | EP2227249B1 (enExample) |
| JP (1) | JP2011506433A (enExample) |
| CN (1) | CN102026658A (enExample) |
| AU (1) | AU2008336295B2 (enExample) |
| CA (1) | CA2708260A1 (enExample) |
| NZ (1) | NZ586367A (enExample) |
| WO (1) | WO2009075646A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2498812A4 (en) * | 2009-11-13 | 2013-05-22 | Bengt Guss | IMMUNIZATION COMPOSITION FOR REDUCING STREPTOCOCCAL INFECTIONS |
| EP3135684B1 (en) | 2010-05-26 | 2023-06-28 | Intervacc AB | Vaccine against streptococcal infections based on recombinant fusion proteins |
| EP2949340A1 (en) * | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| GB201502306D0 (en) | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| WO2021254479A1 (zh) * | 2020-06-18 | 2021-12-23 | 上海宝济药业有限公司 | 一种免疫球蛋白降解酶IdeE的突变体 |
| CN117042805A (zh) * | 2021-04-05 | 2023-11-10 | 株式会社Lg化学 | 对抗冠状病毒的疫苗组合物 |
| JP2024547125A (ja) * | 2021-12-22 | 2024-12-26 | 上海宝済薬業股▲ふん▼有限公司 | 免疫グロブリン分解酵素ＩｄｅＥの変異体の用途 |
| CN114437235B (zh) * | 2022-01-04 | 2024-02-09 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用 |
| US12091694B2 (en) | 2022-11-18 | 2024-09-17 | Seismic Therapeutic, Inc. | Fc fusion molecules and uses thereof |
| EP4646476A1 (en) | 2023-01-06 | 2025-11-12 | Seismic Therapeutic, Inc. | Protease variants and uses thereof |
| WO2025054602A1 (en) * | 2023-09-08 | 2025-03-13 | The Texas A&M University System | Protein for the serological detection of streptococcus equi subspecies equi exposure or infection |
| CN118497176B (zh) * | 2024-07-16 | 2025-01-21 | 苏州康聚生物科技有限公司 | 一种免疫球蛋白降解酶 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR241545A1 (es) | 1985-07-12 | 1992-08-31 | Cornell Res Foundation Inc | Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos. |
| US5583014A (en) | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
| SE9003374D0 (sv) | 1990-10-22 | 1990-10-22 | Alfa Laval Agri Int | A collagen binding protein as well as its preparation |
| SE9302855D0 (sv) | 1993-09-06 | 1993-09-06 | Martin Lindberg | Method and means for producing plasmaproteinase inhibitor binding proteins |
| IES960488A2 (en) | 1996-07-03 | 1997-11-19 | Trinity College Dublin | Subunit Vaccine for Streptococcus Equi |
| CA2243730C (en) * | 1997-07-29 | 2009-12-22 | Akzo Nobel N.V. | Streptococcus equi vaccine |
| SE9804491D0 (sv) | 1998-12-22 | 1998-12-22 | Bengt Guss | Novel fibronectin-binding protein |
| US6887480B1 (en) | 1999-06-10 | 2005-05-03 | Medimmune, Inc. | Streptococcus pneumoniae proteins and vaccines |
| ES2264419T3 (es) * | 1999-06-10 | 2007-01-01 | Medimmune, Inc. | Vacunas y proteinas de streptococcus pneumoniae. |
| US8404245B2 (en) * | 2002-10-11 | 2013-03-26 | Intervacc Ab | Immunization of non-human mammals against Streptococcus equi |
| AU2007233252C1 (en) * | 2006-03-29 | 2013-05-23 | Boehringer Ingelheim Animal Health USA Inc. | Vaccine against Streptococci |
-
2008
- 2008-12-12 NZ NZ586367A patent/NZ586367A/en unknown
- 2008-12-12 AU AU2008336295A patent/AU2008336295B2/en not_active Ceased
- 2008-12-12 US US12/747,843 patent/US20110020403A1/en not_active Abandoned
- 2008-12-12 EP EP08858722.5A patent/EP2227249B1/en active Active
- 2008-12-12 WO PCT/SE2008/051445 patent/WO2009075646A1/en not_active Ceased
- 2008-12-12 CA CA2708260A patent/CA2708260A1/en not_active Abandoned
- 2008-12-12 CN CN2008801269094A patent/CN102026658A/zh active Pending
- 2008-12-12 JP JP2010537898A patent/JP2011506433A/ja active Pending
-
2013
- 2013-05-13 US US13/893,212 patent/US9987342B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506433A5 (enExample) | ||
| CN113801207B (zh) | 新型冠状病毒的串联表位多肽疫苗及其应用 | |
| CN108624601B (zh) | 酵母表达的柯萨奇病毒a10病毒样颗粒及其应用 | |
| CN107384944B (zh) | 酵母表达的柯萨奇病毒a6病毒样颗粒及其应用 | |
| CA2325566A1 (en) | Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates | |
| CN103068838B (zh) | 基于重组蛋白的抗链球菌感染疫苗 | |
| JP2008529558A5 (enExample) | ||
| JP2006525330A5 (enExample) | ||
| JP2002512026A5 (enExample) | ||
| JP2007525456A (ja) | ウマ２型インフルエンザウイルスのｈａ１を発現するｄｎａワクチン | |
| JP2025174963A (ja) | ヘモフィルス・パラスイスに対する新規ワクチン | |
| Gao et al. | A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice | |
| US20030007979A1 (en) | Vaccine compositions | |
| US10960066B2 (en) | Streptococcus pneumoniae vaccine | |
| CN103724413B (zh) | 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用 | |
| CN103421817B (zh) | 人工合成的猪繁殖与呼吸综合征病毒多表位基因及应用 | |
| CA2501621A1 (en) | Immunization of non-human mammals against streptococcus equi | |
| JP2002516662A5 (enExample) | ||
| WO2014146603A1 (zh) | 败血性巴氏杆菌毒素重组蛋白及其应用 | |
| CN102847168B (zh) | 一种预防奶牛乳腺炎的核酸疫苗PV-Fn的设计及其构建 | |
| CN117982634A (zh) | 高致病性猪繁殖与呼吸综合征病毒亚单位疫苗筛选及应用 | |
| US20220296701A1 (en) | Synthetic plasmid dna vaccine expressing a codon-optimized sars-cov-2 spike protein and methods for its use | |
| WO2022127820A1 (zh) | 病原样抗原疫苗及其制备方法 | |
| CN100409900C (zh) | 葡萄球菌肠毒素a基因及其编码蛋白的新用途 | |
| CN103910786A (zh) | 无乳链球菌BibA重组蛋白及其编码基因、制备方法和应用 |